For most governments and policy makers, the healthcare sector is a top priority. Increased regulatory scrutiny, pricing and cost pressure, and an aging population, combined with the COVID-19 pandemic, have propelled the industry to the top of the global agenda. And while challenges must be tackled on a country-by-country basis, the ultimate objective is universal – delivering the best possible care to the greatest number of people, at the lowest possible cost.

As a heavily regulated industry, the sector is appealing to private equity investors and venture capitalists, attracted by the lower risk it offers. Equally, opportunities present themselves for private care providers and real-estate investors, through care homes and assisted living, where access to good-quality healthcare is critical.

With so many disparate parties involved in healthcare, and so much burgeoning opportunity, the legal considerations are expansive. Osborne Clarke has a strong track record in acting for clients across the entire sector, including central health and social-care providers, government bodies, public health authorities, hospital and care-home owners, corporate entities, start-ups and new market entrants.

Our Europe-wide team has the both the experience and expertise to provide specialist legal support in all required areas, including funding, acquisitions, care provision, regulation, employment and incentives, and protection of intellectual property. We also offer clients a dedicated healthcare technology practice, advising companies and investors that are transforming the way therapies and patient services are delivered.

In continental Europe and the UK, clients can call on strong regulatory practices, while members of the team have specific experience within their own countries.

Experience


Roche Diagnostics GmbH

Advised Roche Diagnostics GmbH on the revision of their privacy policy and end-user licence agreements.

Roche Diagnostics GmbH

Advised Roche Diagnostics GmbH on a cloud-based solution for securely hosting critical medical data in compliance with data protection laws in over 30 countries.

Sirigen Group Ltd

Advised medical technology Sirigen Group Ltd on its acquisition by Becton, Dickinson and Company, a leading global medical technology company, for an undisclosed sum.

Takeda Ventures

Advised Takeda Ventures, Inc and Takeda Pharmaceuticals on the investment and formation of a drug discovery collaboration with Heptares Therapeutics Ltd.

Spanish Association for Self-Care Health

Advised on data protection matters.

2